Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

FDA pilot programme in support of global harmonisation.

Maria E Donawa¹

¹Donawa & Associates Ltd., Via Fonte di Fauno 22, I-00153 Rome, Italy. donawa@srd.it

Medical Device Technology

|December 20, 2003

Summary

The United States Food and Drug Administration (FDA) pilot program aims to streamline medical device conformity assessments globally. European manufacturers are encouraged to participate in this initiative for regulatory harmonization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

New European guidance on borderline products.

Medical device technology·2009

Same author

The evolving process of European combination product review, Part II.

Medical device technology·2009

Same author

The evolving process of European combination product review, Part I.

Medical device technology·2008

Same author

Who owns the 510(k)?

Medical device technology·2008

Same author

FDA draft guidance on computerised systems used in clinical trials.

Medical device technology·2005

Same author

The essential element of ethics.

Medical device technology·2004

Area of Science:

Regulatory Affairs
Medical Device Compliance
Global Harmonization

Background:

Achieving worldwide medical device conformity to regulatory requirements is a significant challenge.
Global harmonization of medical device regulations is an ongoing objective in the healthcare industry.

Purpose of the Study:

To introduce the United States Food and Drug Administration's (FDA) premarket review pilot program.
To discuss the benefits of this program for global regulatory harmonization.
To encourage European manufacturers to consider participation.

Main Methods:

Discussion of the FDA's new premarket review pilot program.
Analysis of the program's potential impact on international regulatory alignment.
Exploration of advantages for European medical device manufacturers.

Main Results:

The FDA is actively supporting global harmonization through a new pilot program.
Participation in the pilot program offers potential benefits for manufacturers navigating international regulations.

Conclusions:

The FDA's initiative represents a step towards a unified global regulatory document for medical devices.
European manufacturers should evaluate the strategic advantages of engaging with this premarket review pilot program.

Related Experiment Videos